SMCI Q4 Beat and FY27 Guide Strengthen Demand Story, but Working Capital and Dilution Caveats Persist

What happened

Super Micro reported Q4 FY26 revenue of $11.12 billion, a 77.55% EPS beat, guided FY27 sales to $65-72 billion, and disclosed record backlog entering fiscal 2027. This builds on the July preliminary update that had signaled a sharp gross margin rebound to 15-17%, and the final results confirm revenue landed slightly above the low end of prior guidance. However, the company's balance sheet remains under severe strain, with accounts receivable of $8.4 billion and inventory of $11.1 billion as of March 31, 2026, and operating cash flow negative $7.56 billion over nine months. The June equity and equity-linked financing added 45.45 million shares immediately, and mandatory converts imply total dilution of roughly 23-26%, while SEC and export-control investigations continue. The market is now focused on whether the backlog and margin improvement convert into sustainable cash generation without further dilution, leaving the stock in a wait-and-see mode despite the headline beat.

Implication

The fiscal 2027 revenue guide of $65-72 billion and record backlog suggest demand is not the bottleneck, but fulfillment remains capital-intensive and dependent on financing. The Q4 gross margin rebound to 15-17% must be confirmed over subsequent quarters to prove it is structural and not a one-time mix benefit. Accounts receivable and inventory need to stop growing faster than revenue, and operating cash flow must turn sharply less negative, otherwise further dilution is likely. The legal and governance overhang adds risk to financing access and customer trust, which could disrupt the current demand momentum. Until these operational and financial metrics improve, the risk-reward remains unattractive at current prices, and only a pullback toward the $26 entry level or clear evidence of cash conversion would justify a more constructive stance.

Thesis delta

Before earnings, the thesis was a WAIT pending Q4 confirmation of durable margins and cash conversion. The final Q4 report confirms strong demand and a significant EPS beat, but it does not resolve the working capital strain, dilution risk, or legal overhang, and the FY27 guide is aggressive relative to current balance sheet capacity. The thesis remains WAIT, with the shift being that demand is now proven while cash conversion remains the critical unresolved variable.